Ping An Biomedical Co

Ping An Biomedical Co Financial Leverage

The Financial Leverage (Equity Multiplier) of Ping An Biomedical Co (PASW) as of Nov 20, 2026 is -7.91. In the previous year, Financial Leverage (Equity Multiplier) was -13.63 — a change of -41.96% (higher).

Financial Leverage

-7.91

YoY

-41.96%

Last updated:

Financial Leverage (Equity Multiplier) of Ping An Biomedical Co is 2024 -7.91 . Financial Leverage (Equity Multiplier) of Ping An Biomedical Co was 2023 -13.63 . It decreases by -41.96% higher compared to the previous year.

The Ping An Biomedical Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2022
17.82 CNY
Jan 1, 2023
-13.63 CNY
Jan 1, 2024
-7.91 CNY
The Ping An Biomedical Co Financial Leverage history
YEARFinancial LeverageYoY
-7.91-41.96%
-13.63-176.48%
17.82—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ping An Biomedical Co Stock analysis

What does Ping An Biomedical Co do? Majestic Ideal Holdings Ltd. generates revenue by providing supply chain management services within the apparel industry. The firm delivers one-stop solutions to customers for a broad range of yarn products, textiles, and finished garments. These services cover functions within the supply chain, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The company employs 7 full-time employees to support these operations. The business is organized into two distinct segments. The Sales of Yarns segment is mainly engaged in the provision of yarn products, textiles, and other products. The Sales of Finished Garments segment is mainly engaged in the provision of finished garments. Through these segments, the firm provides end-to-end supply chain solutions to its clients. Ping An Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ping An Biomedical Co stock

Financial Leverage (Equity Multiplier) of Ping An Biomedical Co is -7.91 in 2024.

Financial Leverage (Equity Multiplier) of Ping An Biomedical Co changed from -13.63 to -7.91, representing a -41.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Ping An Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Ping An Biomedical Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Ping An Biomedical Co

All Key Metrics — Ping An Biomedical Co